566883-83-8

Upstream product

• 566883-81-6 N-(p-methylbenzyl)-N-(p-toluenesulfonyl)glycine methyl ester 
• 98-59-9 p-toluenesulfonyl chloride 
• 104-81-4 4-Methylbenzyl bromide 
• 3551-20-0 N-tosylglycine t-butyl ester 
• 104-82-5 4-Methylbenzyl chloride 
• 2645-02-5 methyl tosylglycinate 
• 245364-74-3 [(4-methyl-benzyl)-(toluene-4-sulfonyl)-amino]-acetic acid tert-butyl ester 

Downstream Products

• 566883-89-4 4-(3,4-dimethoxy-2-methoxymethoxymethylphenyl)-6-methyl-N-(p-toluenesulfonyl)-1,2-dihydroisoquinoline 
• 566883-87-2 N-(p-toluenesulfonyl)-6-methyl-4-(trifluoromethylsulfonyloxy)-1,2-dihydroisoquinoline 
• 566883-85-0 6-methyl-N-(p-toluenesulfonyl)-1,2,3,4-tetrahydroisoquinol-4-one 
• 245365-03-1 N-benzyloxy-2-[(4-methyl-benzyl)-(toluene-4-sulfonyl)-amino]-acetamide 

Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands

Dinapsoline ((2); (±)-dihydroxy-2,3,7,11b-tetrahydro-1H-naphth[1,2,3-de]isoquinoline) is a full D1 dopamine agonist that also has significant D2 receptor affinity. Based on a similar pharmacophore, dinapsoline has pharmacological sim

Synthesis of an array of potential matrix metalloproteinase inhibitors using a sequence of polymer-supported reagents

Polymer-supported reagents and sequestering agents may be used to generate an array of variously substituted hydroxamic acid derivatives as potential inhibitors of matrix metalloproteinases without any chromatographic purification step.